CRISPR-Edited Peanuts Target Major Allergens in First US Field Trial
SOURCE: GLOBAL-AGRICULTURE.COM
OCT 04, 2026
BEAM: Advancing pivotal gene editing programs with strong data, regulatory momentum, and platform scalability
SOURCE: TRADINGVIEW.COM
SEP 09, 2026
Sep 9, 2026, 23:58 GMT+5:30
Significant pipeline progress includes pivotal trials for AATD and sickle cell, with strong clinical data and regulatory alignment for accelerated approval. The platform enables rapid expansion to new indications, with a robust commercial and financial outlook supporting multiple blockbuster opportunities.
LATEST NEWS
Computer Vision
Dual-Stream AI Combines Compression Clues and Deep Vision to Expose Doctored Images
OCT 10, 2026
WHAT'S TRENDING
Data Science
5 Imaginative Data Science Projects That Can Make Your Portfolio Stand Out
OCT 05, 2022
Similar articles you can read
Neocrop raises $2.75M seed to scale high-fibre gene-edited wheat
SOURCE: APP.DEALROOM.CO
OCT 04, 2026
Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing
SOURCE: BIOENGINEER.ORG
SEP 27, 2026
Discovery of CRISPR's long lost ancestor may expand gene-editing toolkit
SOURCE: PHYS.ORG
SEP 18, 2026
